These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9357513)

  • 1. 6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]- indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist.
    Bromidge SM; Duckworth M; Forbes IT; Ham P; King FD; Thewlis KM; Blaney FE; Naylor CB; Blackburn TP; Kennett GA; Wood MD; Clarke SE
    J Med Chem; 1997 Oct; 40(22):3494-6. PubMed ID: 9357513
    [No Abstract]   [Full Text] [Related]  

  • 2. Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectra.
    Kantor S; Jakus R; Molnar E; Gyongyosi N; Toth A; Detari L; Bagdy G
    J Pharmacol Exp Ther; 2005 Nov; 315(2):921-30. PubMed ID: 16085759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
    Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonists.
    Bromidge SM; Davies S; Duckworth DM; Forbes IT; Jones GE; Jones J; King FD; Blackburn TP; Holland V; Kennett GA; Lightowler S; Middlemiss DN; Riley GJ; Trail B; Wood MD
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1867-70. PubMed ID: 10969987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of 5-HT2C receptor ligands on place conditioning and locomotor activity in rats.
    Mosher T; Hayes D; Greenshaw A
    Eur J Pharmacol; 2005 May; 515(1-3):107-16. PubMed ID: 15896731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist.
    Kennett GA; Wood MD; Bright F; Trail B; Riley G; Holland V; Avenell KY; Stean T; Upton N; Bromidge S; Forbes IT; Brown AM; Middlemiss DN; Blackburn TP
    Neuropharmacology; 1997; 36(4-5):609-20. PubMed ID: 9225286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of septo-hippocampal activity by 5-hydroxytryptamine(2C) receptors.
    Hajos M; Hoffmann WE; Weaver RJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):605-15. PubMed ID: 12734389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolytic agents.
    Bromidge SM; Dabbs S; Davies S; Duckworth DM; Forbes IT; Jones GE; Jones J; King FD; Saunders DV; Blackburn TP; Holland V; Kennett GA; Lightowler S; Middlemiss DN; Riley GJ; Trail B; Wood MD
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1863-6. PubMed ID: 10969986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
    Kimura Y; Naitou Y; Wanibuchi F; Yamaguchi T
    Eur J Pharmacol; 2008 Jul; 589(1-3):157-62. PubMed ID: 18582863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists.
    Ahmed M; Briggs MA; Bromidge SM; Buck T; Campbell L; Deeks NJ; Garner A; Gordon L; Hamprecht DW; Holland V; Johnson CN; Medhurst AD; Mitchell DJ; Moss SF; Powles J; Seal JT; Stean TO; Stemp G; Thompson M; Trail B; Upton N; Winborn K; Witty DR
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4867-71. PubMed ID: 16143522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze.
    Jones N; Duxon MS; King SM
    Psychopharmacology (Berl); 2002 Nov; 164(2):214-20. PubMed ID: 12404085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolines.
    Bromidge SM; Dabbs S; Davies DT; Duckworth DM; Forbes IT; Ham P; Jones GE; King FD; Saunders DV; Starr S; Thewlis KM; Wyman PA; Blaney FE; Naylor CB; Bailey F; Blackburn TP; Holland V; Kennett GA; Riley GJ; Wood MD
    J Med Chem; 1998 May; 41(10):1598-612. PubMed ID: 9572885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo.
    Millan MJ; Dekeyne A; Gobert A
    Neuropharmacology; 1998 Jul; 37(7):953-5. PubMed ID: 9776391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
    Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
    Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety.
    Martin JR; Ballard TM; Higgins GA
    Pharmacol Biochem Behav; 2002 Apr; 71(4):615-25. PubMed ID: 11888553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand dependency of 5-hydroxytryptamine 2C receptor internalization.
    Schlag BD; Lou Z; Fennell M; Dunlop J
    J Pharmacol Exp Ther; 2004 Sep; 310(3):865-70. PubMed ID: 15113845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
    Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
    J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of SB-243213, a selective 5-HT(2C) receptor antagonist, on the rat sleep profile: a comparison to paroxetine.
    Smith MI; Piper DC; Duxon MS; Upton N
    Pharmacol Biochem Behav; 2002 Apr; 71(4):599-605. PubMed ID: 11888551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine.
    Grottick AJ; Corrigall WA; Higgins GA
    Psychopharmacology (Berl); 2001 Sep; 157(3):292-8. PubMed ID: 11605085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study.
    Invernizzi RW; Pierucci M; Calcagno E; Di Giovanni G; Di Matteo V; Benigno A; Esposito E
    Neuroscience; 2007 Feb; 144(4):1523-35. PubMed ID: 17161544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.